Abstract
Introduction: The development of antibody-drug conjugates (ADCs) have revolutionized treatment for breast cancer. Sacituzumab govitecan (SG), a Trop2-......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
